Entero Therapeutics, Inc.
ENTO
$0.54
$0.055711.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.40K | 163.50K | 366.80K | 662.50K | 3.43M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 233.90K | 145.30K | 305.50K | 554.40K | 4.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 83.17M | 83.17M | 83.17M | 83.17M | -- |
| Total Current Assets | 83.46M | 83.48M | 83.84M | 84.39M | 7.49M |
|
|
|||||
| Total Current Assets | 83.46M | 83.48M | 83.84M | 84.39M | 7.49M |
| Net Property, Plant & Equipment | -- | 126.80K | 144.40K | 163.10K | 207.20K |
| Long-term Investments | 1.68M | 1.68M | 1.68M | 1.68M | 20.04M |
| Goodwill | 1.68M | 1.68M | 1.68M | 1.68M | 20.04M |
| Total Other Intangibles | -- | -- | -- | -- | 365.50K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 56.10K | 119.80K | 149.80K | 53.30K | 63.03M |
| Total Assets | 85.20M | 85.41M | 85.82M | 86.29M | 91.13M |
|
|
|||||
| Total Accounts Payable | 2.85M | 2.96M | 2.21M | 2.01M | 2.00M |
| Total Accrued Expenses | 303.90K | 252.00K | 219.20K | 1.82M | 2.55M |
| Short-term Debt | 700.00K | -- | -- | 177.60K | 386.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 135.60K | 81.50K | 79.50K | 77.40K | 71.20K |
| Total Finance Division Other Current Liabilities | 24.75M | 24.25M | 13.18M | 11.29M | 1.16M |
| Total Other Current Liabilities | 24.75M | 24.25M | 13.18M | 11.29M | 1.16M |
| Total Current Liabilities | 28.74M | 27.55M | 15.69M | 15.38M | 6.17M |
|
|
|||||
| Total Current Liabilities | 28.74M | 27.55M | 15.69M | 15.38M | 6.17M |
| Long-Term Debt | -- | -- | -- | -- | 6.40M |
| Short-term Debt | 700.00K | -- | -- | 177.60K | 386.80K |
| Capital Leases | -- | 59.00K | 80.20K | 101.00K | 127.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 571.20K |
| Total Liabilities | 28.74M | 27.61M | 15.77M | 15.49M | 13.27M |
|
|
|||||
| Common Stock & APIC | 198.43M | 198.51M | 198.52M | 196.69M | 194.94M |
| Retained Earnings | -203.65M | -202.39M | -190.15M | -187.57M | -178.76M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -5.22M | -3.88M | 8.37M | 9.12M | 16.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 61.68M | 61.68M | 61.68M | 61.68M | 61.68M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 61.68M | 61.68M | 61.68M | 61.68M | 61.68M |
|
|
|||||
| Total Common Equity | -5.22M | -3.88M | 8.37M | 9.12M | 16.18M |
| Total Preferred Equity | 61.68M | 61.68M | 61.68M | 61.68M | 61.68M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 56.46M | 57.80M | 70.05M | 70.80M | 77.86M |
|
|
|||||